Reuters logo
BRIEF-Sunovion Pharmaceuticals to acquire Cynapsus Therapeutics
2016年8月31日 / 晚上9点22分 / 1 年前

BRIEF-Sunovion Pharmaceuticals to acquire Cynapsus Therapeutics

Aug 31 (Reuters) - Cynapsus Therapeutics Inc

* Sunovion Pharmaceuticals to acquire Cynapsus Therapeutics

* Deal values Cynapsus at about US$624 million (or about CAN$820 million)

* Acquisition will be funded with cash on hand

* Cynapsus will receive US$40.50 per common share in cash

* Holders of co’s warrants,stock options to get cash payment equal to difference between US$40.50,exercise price of such warrant or stock option

* BofA Merrill Lynch serves as financial advisor to Cynapsus

* Nomura Securities International, Inc. serves as exclusive financial advisor to Sunovion

* Sunovion would acquire Cynapsus’ product candidate, APL-130277 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below